期刊文献+

保罗样激酶1与上皮钙黏蛋白在肝癌中的表达及预后价值 被引量:4

Expression and prognostic value of Polo-like kinase 1,E-cadherin in the patients with hepatocellular carcinoma
原文传递
导出
摘要 目的研究比较肝细胞肝癌中保罗样激酶1(PLK1)及上皮钙黏蛋白(E-cadhefin)的表达与临床病理因素关系及对预测肝癌移植术后复发的价值。方法应用 RT-PCR 检测 PLK1 及E-cadherin 在转录水平的表达趋势;应用免疫组织化学检测两者蛋白水平的表达情况,并与临床病理因素及术后无瘤生存期、复发率进行比较分析。结果在转录水平方面,50对肝癌及癌旁冰冻标本中PLK1及 E-cadherin 的表达阳性率分别为90.0%与96.0%,PLK1 mRNA 癌高于癌旁,E-cadherin 则无趋势;50例肝癌石蜡标本中 PLK1 阳性表达及 E-cadherin 低表达的阳性率分别为60.0%与50.0%,PLK1阳性表达仅与术前血清 AFP 相关,E-cadherin 降低与临床病理因素均无相关性,PLK1阳性表达与 E-cadherin 低表达之间相关,Kaplan-Meier 分析结果示 PLK1、E-cadherin、肝癌大小、门静脉癌栓、Edmondson 分级、术前血清 AFP 等均与复发相关,Cox 回归分析示仅 PLK1 有统计学意义。结论PLK1阳性表达与 E-cadherin 低表达预示肝癌移植术后有较高的复发率,且 PLK1可作为复发的独立风险因素。 Objectives To study the expression of Polo-like kinase 1 (PLK1) and E-cadherin in the tissues of hepatocellular carcinoma, and to disscuss the relationship between them and clinical-pathological features, and to evaluate their prognostic value of hepatocellular carcinoma after liver transplantation. Methods mRNA and protein expression of PLK1, E-cadherin were detected by RT-PCR and immunohistochemistry method respectively, the correlations of them with clinical-pathological data, tumor free time, recurrence rate were compared and analyzed. Results The mRNA expression was observed in 90. 0% for PLK1 and 96. 0% for E-cadherin, and higher in cancerous' tissues than paracancerous' of all cases for PLK1 but no trend for E-cadherin. The positive and decreased expression rate for PLK1 and E- cadherin was observed in 60.0% and 50.0% respectively, the positive PLK1 expression was correlated with preoperative serum et-fetoprotein (AFP) only (X2 = 4. 433, P = 0. 035 ), while E-cadherin expression was associated with none of the clinical-pathological features. There was a correlation between the positive PLK1 and decreased E-cadherinexpression" (X2 = 5. 333, P = 0. 021 ) . PLK1 ( P = 0. 006 ) , E-cadherin ( P = 0. 019) and larger tumor ( P = 0. 019 ) , portal vein tumor thrombi ( P = 0. 030 ) , Edmondson grading ( P = 0. 019), preoperative serum AFP( P = 0. 020) were all correlated with recurrence rate under Kaplan-Meier analysis, while only PLK1 ( RR = 3. 104, P = 0. 009 ) had significant difference under Cox regression analysis. Conclusions The positive PLK1 expression and the decreased E-cadherin expression indicate higher recurrence rate of HCC after liver transplantation, and PLK1 is a independent risk factor.
出处 《中华外科杂志》 CAS CSCD 北大核心 2007年第19期1354-1358,共5页 Chinese Journal of Surgery
基金 国家"973"重点基础研究项目资助(2003CB515501)
关键词 肝细胞 复发 保罗样激酶1 上皮钙黏蛋白 Carcinoma, hepatocellular Recurrence Pole-like kinase 1 E-cadherin
  • 相关文献

参考文献23

  • 1Ito Y, Nakamura Y, Yoshida H, et al. Polo-Like Kinase 1 expression in medullary carcinoma of the thyroid: its relationship with clinicopathological features. Pathobiology, 2005, 72: 186- 190.
  • 2Fiorentino M, Altimari A, Ravaioli M, et al. Predictive value of biological markers for hepatocellular carcinoma patients treated with orthotopic liver transplantation. Clin Cancer Res, 2004, 10 : 1789-1795.
  • 3Takai N, Hamanaka R, Yoshimatsu J, et al. Polo-like kinases (Plks) and cancer. Oncogene, 2005, 24: 287-291.
  • 4Tokumitsu Y, Moil M, Tanaka S,et al. Prognostic significance of polo-like kinase expression in esophageal carcinoma. Int J Oncol, 1999, 15:687-692.
  • 5Weichert W, Denkert C, Schmidt M, et al. Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer, 2004, 90:815-821.
  • 6Weichert W, Schmidt M, Gekeler V, et al. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades. Prostate, 2004, 60:240-245.
  • 7Yamada S, Ohira M, Horie H, et al. Expression profiling and differential screening between hepatoblastomas and the corresponding normal livers: identification of high expression of the PLK1 oncogene as a poor-prognostic indicator of hepatoblastomas. Oncogene, 2004, 23:5901-5911.
  • 8Gray PJ Jr, Bearss DJ, Hart H, et al. Identification of human polo-like kinase 1 as a potential therapeutic target in pancreatic cancer. Mol Cancer Ther, 2004, 3:641-646.
  • 9Mito K, Kashima K, Kikuchi H, et al. Expression of Polo-Like Kinase (PLK1) in non-Hodgkin's lymphomas. Leuk Lymphoma, 2005, 46:225-231.
  • 10Weichert W, Kristiansen G, Winzer KJ, et al. Polo-like kinase isoforms in breast cancer: expression patterns and prognostic implications. Virchows Arch, 2005, 446:442-450.

二级参考文献24

  • 1兰斌,刘炳亚,朱正纲.PLK1在细胞周期生物学的研究进展[J].医学分子生物学杂志,2005,2(1):65-67. 被引量:15
  • 2孙成林,段志泉,辛世杰,冯宗承,张京红,古峻,张强.血管紧张素Ⅱ1型受体的短发夹环RNA抑制大鼠血管平滑肌细胞增殖的研究[J].中华外科杂志,2004,42(22):1357-1362. 被引量:4
  • 3马晋平,詹文华,汪建平,彭俊生,高劲松,殷勤伟.小分子干扰RNA特异性抑制胃癌SGC7901细胞人端粒酶催化亚单位基因表达的研究[J].中华外科杂志,2004,42(22):1372-1376. 被引量:10
  • 4Tokumitsu Y,Mori M,Tanaka S,et al.Prognostic significance of polo-like kinase expression in esophageal carcinoma.Int J Oncol,1999,15:687-692.
  • 5Wolf G,Hildenbrand R,Schwar C,et al.Polo-like kinase:a novel marker of proliferation:correlation with estrogen-receptor expression in human breast cancer.Pathol Res Pract,2000,196:753-759.
  • 6Knecht R,Elez R,Oechler M,et al.Prognostic significance of polo-like kinase (PLK) expression in squamous cell carcinomas of the head and neck.Cancer Res,1999,59:2794-2797.
  • 7Liu X,Erikson RL.Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.Proc Natl Acad Sci,2003,100:5789-5794.
  • 8Tong C,Fan HY,Lian L,et al.Polo-like kinase-1 is a pivotal regμlator of microtubule assembly during mouseoocyte meiotic maturation,fertilization,and early embryonic mitosis.Biol Reprod,2002,67:546-554.
  • 9Sumara I,Vorlaufer E,Stukenberg PT,et al.The dissociation of cohesin from chromosomes in prophase is regμlated by Polo-like kinase.Mol Cell,2002,9:515-525.
  • 10Neef R,Preisinger C,Sutcliffe J,et al.Phosphorylation of mitotic kinesin-like protein 2 by polo-like kinase 1 is required for cytokinesis.J Cell Biol,2003,162:863-875.

共引文献11

同被引文献16

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部